Bayer, a leading company in key areas of radiology and cardiology, and Attralus, Inc. (Attralus), a clinical stage biopharmaceutical company focused on developing medicines and diagnostics for ...

Bayer to acquire AT-01 & AT-05, investigational molecular imaging agents for the diagnosis of cardiac amyloidosis from Attralus: Berlin, Germany Wednesday, January 14, 2026, 11:00 ...

Researchers developed an AI model to detect myocardial ischemia and coronary microvascular and vasomotor dysfunction using ...

In Nairobi, Kenya’s capital, the Aga Khan University Hospital is positioning itself to solve two of Africa’s nagging ...

Bayer, looking to bolster its position in both imaging and cardiac medicine, struck a deal to snap up two experimental imaging agents and thereby enter the diagnostic tracers development space. | ...

Cambridge researchers have discovered that an existing therapy which boosts protective immune cells in people who recently ...

Recent medical research indicates that the heightened risk of heart disease observed in patients with depression or anxiety ...

Cervical lymphadenopathy presents a shared anatomic challenge for clinicians, yet it serves as the divergent starting point ...

Anthracyclines are among the most widely used chemotherapy drugs and have been a mainstay of cancer treatment for more than ...

Camberley nurse Clare Garrett, 45, says she was left needing a wheelchair after she had a private MRI scan in June 2024 ...

Patients with pre-existing high blood pressure are more likely to be susceptible to heart damage caused by anthracyclines, the most widely used chemotherapy drugs for cancer treatment for more than 30 ...

Infectious endocarditis (IE) represents a severe medical condition marked by infectious inflammation of the heart's inner ...